Comparison
Companies and funds side by side across all metrics. The best value in each row is highlighted.
Performance from the same starting point
All series start at 100 on the same day. The price is adjusted for dividends.
Green background = the best value in the row (the lowest one for cost metrics).
| Loading… |
Compared securities
- Repligen Corporation (RGEN): price 162,78 USD, market cap 10,4 mld. USD
- Neurocrine Biosciences, Inc. (NBIX): price 165,31 USD, market cap 16,7 mld. USD, P/E 24,5